Document is current
Any future updates will be listed below
-
Authors
Mura, Rebecca
Zolda, Pamela
Ledda, Roberta Eufrasia
Baldwin, David R.
Hardavella, Georgia
Seijo, Luis
Kerpel-Fronius, Anna
Chorostowska-Wynimko, Joanna
Blum, Torsten Gerriet
Prosch, Helmut https://orcid.org/0000-0002-6119-6364
-
Funding
Funding for this research was provided by:
European Union (101101187)
- License Information
-
More Information
Article History
Received: 13 February 2026
Revised: 7 May 2026
Accepted: 30 June 2026
First Online: 29 July 2026
Declarations
Ethics approval: Not applicable.
Consent for publication: Not applicable.
Competing interests: H.P.: Speaker Honoria: AstraZeneca, BMS, Boehringer Ingelheim, Janssen, MSD, Novartis, Roche, Sanofi, Siemens Healthcare, Takeda. Advisory Boards: BMS, Boehringer Ingelheim, MSD, Roche/Intermune, Sanofi. Travel grants: Boehringer Ingelheim. Research support: Boehringer Ingelheim, AstraZeneca, Siemens Healthineers, Austrian Federal Ministry for Labor and Economy, the National Foundation for Research, Technology and Development, and the Christian Doppler Research Association, EU Commission (EU4Health, Horizon Europe Health). The other authors declare that they have no competing interests.
